Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Zhang, Yuanyuan, Chen, Hongyan, Mo, Hongnan, Hu, Xueda, Gao, Ranran, Zhao, Yahui, Liu, Baolin, Niu, Lijuan, Sun, Xiaoying, Yu, Xiao, Wang, Yong, Chang, Qing, Gong, Tongyang, Guan, Xiuwen, Hu, Ting, Qian, Tianyi, Xu, Binghe, Ma, Fei, Zhang, Zemin, Liu, Zhihua·2021·Cancer Cell

DOI 10.1016/j.ccell.2021.09.010

Cited by (792)

Items 401–500 of 792

A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment
Rui Fu, Chao Zhang, Mengmeng Song, Xuan Gao, Fang Li, Miao Cai, Ben‐Yuan Jiang, Xue-Ning Yang, Yi-Long Lung Cancer Wu, Wen‐Zhao Zhong · 2025 · Cancer Letters
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
Jinhao Chen, Qianru Wang, Hong-Yan Wu, Xiaofei Huang, Chunyu Cao · 2025 · Frontiers in Oncology
H2O2 self-supplying cascade catalytic nanoreactors amplify oxidative stress for augmented cuproptosis-driven multimodal synergistic therapy of breast cancer
Zhe Wen, Rui-Rui Zhao, Xiao Wei Wu, Chunlei Liu, Chunzhao Liu · 2025 · Colloids and Surfaces B Biointerfaces
Advances in TIL therapy: Expanding the horizons beyond melanoma
Pauline Wiertsema, Yadi Tan, John B.A.G. Haanen, Tom T. P. Seijkens, Inge Jedema · 2025 · Med
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy
Zhijie Wu, Shouguo Gao, Xingmin Feng, Haoran Li, Nicolas Sompairac, Shirin Jamshidi, Desmond Choy, Rita Antunes Dos Reis, Qingyan Gao, Sachiko Kajigaya et al. · 2025 · Nature Communications
Targeting CD37 promotes macrophage-dependent phagocytosis of multiple cancer cell types and facilitates tumor clearance in mice
Xinya Gao, Jing Zhang, H Zhang, Xin Liu, Bo Zeng, Huijun Wang, Hanbing Zhang, Weng‐Onn Lui, Xiaoyan Hannah Hui, Hongming Miao et al. · 2025 · Nature Communications
Revolutionizing pharmacological research of traditional Chinese medicine with single-cell omics technologies
Linya Wu, Qifang Wu, Xueting Du, Ling Mu, Haibin Tong · 2025 · Fitoterapia
Positive and negative roles of myeloid cells in cancer immunotherapy
Jaroslav Žák, Judith A. Varner · 2025 · Journal for ImmunoTherapy of Cancer
Injectable Matrix Metalloproteinase-Responsive Polypeptide Hydrogels as Drug Depots for Antitumor Chemo-Immunotherapy
Shuang Liang, Tianran Wang, Junfeng Ding, Jiaxuan Yang, Chaoliang He, Yan Rong · 2025 · Pharmaceutics
Pan-Cancer Single-Cell RNA Sequencing Analysis Refines Multi-Origin Monocyte and Macrophage Lineages
Truc Do Thanh. Nguyen, Andrew Lee, Hyun Jung Park, Nameeta Shah, Bayrta Mandzhieva, Dong‐Sup Lee, Inkyung Jung, Woong‐Yang Park · 2025 · Cancer Immunology Research
Oligoclonal tumor-specific CD8 T-cell revival and IRE1α/XBP1-GDF15-mediated immunosuppressive niches determine neoadjuvant chemoimmunotherapy efficacy in cervical cancer
Guangxu Cao, Yuhan Wang, Huimin Zeng, Yong Zhi, Yi Guo, Mengting Xu, Yetian Ruan, Ying Wang, Yuhang Xiao, Jianqiao Lu et al. · 2025 · Journal for ImmunoTherapy of Cancer
GPR183 potentiates CAR-T cell infiltration and antitumor immunity through a positive feedback loop involving the oxysterol 7α,25-OHC
Rui Guo, Chang Guo, Sen Qin, Zhiwen Lin, Jinlian Tong, Yiran Wang, Zixuan Zhao, Wen Zuo, Qing Gao, Qin Tan et al. · 2026 · Molecular Cancer
Decitabine/paclitaxel co-delivery systems modified with anti-PD-L1 antibodies mediate chemoimmunotherapy for Triple negative breast cancer
Yang He, Qin Hu, Liting Wang, Chuanrong Chen · 2023 · Materials & Design
Identification of exosome-related gene signature as a promising diagnostic and therapeutic tool for breast cancer
Qitong Chen, Qin Zhou · 2024 · Heliyon
Immunosuppressive microenvironment of liver restrains chemotherapeutic efficacy in triple-negative breast cancer
Ming-Duo Liu, Mengjia Qian, Wen Sun, Xiaowei Sun, Yue Sun, Mu-Xin Yu, Xin-Yu Tang, X. Mao, Chang Sun, Qi Qi et al. · 2025 · Journal for ImmunoTherapy of Cancer
Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer
Zhe-Ming Liu, Song-Jiang He, Z. Huang, Jiahui Liu, Yiping Gong, Yi Yao, Xue Zhang · 2023 · Thoracic Cancer
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian Cancer
Antonia Digklia, George Coukos, Krisztián Homicskó · 2022 · Clinical Cancer Research
AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed, Matthew D. Park, Cédric M. Blouin, Sreekumar Balan, Chang Yoon Moon, Jesse Boumelha, Ante Peros, Raphaël Mattiuz, Amanda M. Reid, Camillia S. Azimi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer
Christina Metoikidou, В. К. Карнаухов, Bram Boeckx, Eleonora Timperi, Pierre‐Emmanuel Bonté, Ling Wang, Marion Espenel, Benoît Albaud, Delphine Loirat, Xiaoxiao Wang et al. · 2025 · Cell Reports Medicine
Single-Cell RNA Sequencing + TCR Sequencing Reveal the Proportion and Characteristics of Dual TCR T Cells in Tertiary Lymphoid Structures in Pemphigus
Kai Quan, Ying Yang, Chunming Li, Xinsheng Yao · 2025 · Journal of Investigative Dermatology
Computational modeling of single-cell dynamics data
Wenbo Guo, Zeyu Chen, Jin Gu · 2025 · Briefings in Bioinformatics
Global trends in machine learning applications for single-cell transcriptomics research
Xinyu Liu, Zhen Zhang, Chao Tan, Yinquan Ai, Hao Liu, Yuan Li, Jin Yang, Yongyan Song · 2025 · Hereditas
Integrated single-cell RNA-seq analysis reveals that EZH2 regulates the MIF-CD74 axis to modulate T cell activation and exhaustion in hepatocellular carcinoma
Yangyang Zhou, Yi Xu, Mengfan Ye, Jiayi Xing, Di Chen, AL-Ameer Wail Hussein Ahmed, Al-Rahabi Rehab Abdullah Mohammed Ali, Chenwei Pan, Xiangchou Yang, Zan Shen · 2025 · Journal of Translational Medicine
A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model
Liying Song, Sumin Tang, Xuelei Pi, Yuanyuan Yan, Chenxi Hu, Liang Liu, Hongna Chen, Yating Zhang, Shishi Liu, Dongsheng Yu et al. · 2025 · Journal of Translational Medicine
Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and antitumoral activity upon IL-10 or TGFβ stimulation
Sabrina Traxel, Florian Schmidt, Corina Beerli, Dinh-Van Vuong, Roberto F. Speck, Simon Bredl · 2025 · Journal for ImmunoTherapy of Cancer
The Molecular Landscape and Utility of Multiomic Analyses in Triple-Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic Targets
Conan Juan, Yan Shen Peng · 2025 · Cancers
Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective
Yuan, Zixuan, Liu, Zhiwei, Zhou, Mengying, Wen, Huijuan, Li, Bei · 2026 · Critical Reviews in Oncology/Hematology
Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy
Chang Ma, Hoon Koon Teoh, Yang Zhao, Yifan Wang, Jun Zhao, Ying Liu, Chen Zhao, Hooi Tin Ong · 2026 · Frontiers in Immunology
Investigating the Heterogeneity of Immune Cells in Triple-Negative Breast Cancer at the Single-Cell Level before and after Paclitaxel Chemotherapy
Heng Zhao, Zhang Lin, Yangfan Zhang, Jingjing Liu, Qi Chen · 2023 · International Journal of Molecular Sciences
An overview of multiomics: a powerful tool applied in cancer molecular subtyping for cancer therapy
Yazhu Zou, Zitong Zhao, Yongmei Song · 2023 · Malignancy Spectrum
Discovering explainable biomarkers for breast cancer anti-PD1 response via network Shapley value analysis
Chenxi Sun, Zhi-Ping Liu · 2024 · Comput. Methods Programs Biomed.
Igniting tumour microenvironment in triple-negative breast cancer using a mannose/hyaluronic acid dual-coated Ganoderma polysaccharide-superparamagnetic iron oxide nanocomplex for combinational therapies
Shaofei Yuan, Linjia Zhu, Yi Luo, Xiaoqiang Chen, Haibo Jing, Jiaqi Wang, Xiangyu Su, Meizhen Liang, Zhixiang Zhuang · 2024 · Journal of drug targeting
Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations
Shoma Tamori, Chika Matsuda, Takahiro Kasai, Shigeo Ohno, Kazunori Sasaki, Kazunori Akimoto · 2025 · Scientific Reports
The impact of breast radiotherapy on the tumor genome and immune ecosystem
Aislyn P. Schalck, Tuan Tran, Jianzhuo Li, Emi Sei, Shanshan Bai, Min Shan Hu, Jerome Lin, Scott J. Bright, Samuel J. Reddick, Fei Yang et al. · 2025 · Cell Reports
Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge
Stefania Orecchioni, Paolo Falvo, Giovanna Talarico, Giulia Mitola, Giulia Bravetti, Patrizia Mancuso, Paola Nicoli, Francesco Bertolini · 2023 · Journal of Clinical Medicine
A bibliometric study of the intellectual base and global research hotspots for single-cell sequencing [2009–2022] in breast cancer
Shan Liu, Xudong Joshua Li, Ying Zhang, Yuhan Deng, Zehao Li, Yunan Zhu, Xue Li, Yuefeng Shang, Guang Yang, Xiaolu Zhan et al. · 2024 · Heliyon
Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
Brant G. Wang, Yao Yao, Huanhuan Huang, Jun Zhou, Chao Ni · 2023 · Frontiers in Oncology
Spatial Isoforms Reveal the Mechanisms of Metastasis
Yin Yin, Yuhao Wang, Yu Pei Xiao, Yang Li, Yahui Zhao, Yanfeng Wang, Zhihua Liu · 2024 · Advanced Science
Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy
Zixu Chen, Bang Hu, Keyu Cai, Han Gao, Zhenyu Xian, Shuang Zhang, Zhen Fang, Qian Zhou, Donglin Ren, Qi Zou · 2025 · Cancer Immunology Immunotherapy
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Eleni Skourti, Kotryna Seip, Nadia Mensali, Shakila Jabeen, Siri Juell, Inger Øynebråten, Solveig Pettersen, Olav Engebraaten, Alexandre Corthay, Else Marit Inderberg et al. · 2025 · Breast Cancer Research
Dual targeting OX40 and IL-2 receptor enhances antitumor activity through tumor-infiltrating Treg depletion and CD8 + T-cell proliferation
Shuaishuai Cao, Zhichen Sun, Wenbo Hu, Diyuan Xue, Zuming Yang, Pengfei Duan, Hua Peng, Yang‐Xin Fu, Yong Liang · 2025 · Journal for ImmunoTherapy of Cancer
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer
Alicia M. Chenoweth, Anthony Cheung, Jitesh Chauhan, Rebecca Adams, Gabriel Osborn, Katie Stoker, Melanie Grandits, Roman Laddach, Jennifer Trendell, Blanca Navarro‐Llinas et al. · 2025 · Cancer Research
scGSDR: Harnessing gene semantics for single-cell pharmacological profiling
Yu‐An Huang, Xiyue Cao, Zhu‐Hong You, Yue-Chao Li, Xuequn Shang, Zhi-An Huang · 2025 · Communications Biology
From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy
S C M A Wijnen, Petros Dimitriadis, Lodewyk F.A. Wessels, Christian U. Blank · 2026 · European Journal of Cancer
PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma
Liangyou Gu, Qi Zhang, Qiyang Liang, Cheng Peng, Yaohui Wang, Chenfeng Wang, Zhuoran Li, Yezhen Tan, Y. H. Zhou, Qing Bi et al. · 2026 · Nature Communications
Progress in Natural Products Target Discovery Technology
Qiyuan Pan, Xiao Yuan, Jinmei Jin, Xin Luan, Cheng Luo, Hongzhuan Chen, Weidong Zhang, Haitao Zhang · 2026 · MedComm
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research
R. van Amerongen, M. Bentires-Alj, A. V. van Boxtel, R. Clarke, S. Fre, E. Suarez, R. Iggo, M. Jechlinger, J. Jonkers, Marja L. Mikkola et al. · 2023 · Journal of mammary gland biology and neoplasia
Exploring the “chemo” in chemoimmunotherapy for triple-negative breast cancer
Ting Liu, Leif William Ellisen · 2025 · Cancer Cell
YTHDC2 manipulates anti-tumoral macrophage polarization and predicts favorable outcomes in triple negative breast cancer
Hao Jin, Dongbo Zhang, Yufan Ma, Lanlan Meng, Songyin Huang, Hongjun Su, Jiannan Xu, Yandan Yao · 2025 · npj Precision Oncology
Chemotherapy modulates PD-L1 expression and its combination with immune checkpoint blockade requires precision
Xiayue Zhang, Henglu Cui, Xiaoyu Zhang, Zijian Zhang, Zhaoxiu Liu, Renfang Mao, Yihui Fan, Rong Sun, Miaomiao Chen · 2025 · Critical Reviews in Oncology/Hematology
TCR repertoire and transcriptional signatures of circulating tumour‐associated T cells facilitate effective non‐invasive cancer detection
Fansen Ji, Lin Chen, Zhizhuo Chen, Bin Luo, Yongwang Wang, Xun Lan · 2022 · Clinical and Translational Medicine
A progressive T cell exhaustion program mapped across tissues in patients with lung cancer on immune checkpoint blockade
Carolina Mangana, Barbara B. Maier · 2023 · Cancer Cell
Integrative analysis identifies cancer cell-intrinsic RARRES1 as a predictor of prognosis and immune response in triple-negative breast cancer
Zheng-Heng Yu, Hongjin Liu, Jingming Ye, Yinhua Liu, Ling Xin, Qian Liu, Yuanjia Cheng, Yin Lu, Ling Xu · 2024 · Frontiers in Genetics
PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer
Yiming Cao, LinJing Guan, Li Yang, Changyuan Wei · 2024 · Medicine
CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment
Douglas C. Chung, Noor E. Shakfa, Jehan Vakharia, Kathrin Warner, Nicolas Jacquelot, Azin Sayad, SeongJun Han, Maryam Ghaedi, Carlos R. Garcia-Batres, Jules Sotty et al. · 2025 · Cancer Immunology Research
Single-cell sequencing: accurate disease detection
Xiaoqin Wang, Niannian Li, Wei Wang, Bing Liu · 2025 · Clinical & Translational Oncology
Immune cells within tertiary lymphoid structures are associated with progression‐free survival in patients with locoregional recurrent breast cancer
Jinyuan Gu, Jiaming Wang, Yue Sun, Xinrui Mao, Chao Qian, Xinyu Tang, Wang Ji, Hui Xie, Lijun Ling, Yi Zhao et al. · 2023 · Cancer Medicine
Cancer immunity by tissue‐resident type 1 innate lymphoid cells and killer innate‐like T cells
Jing Zhang, Albert Mao Li, Emily R. Kansler, Ming O. Li · 2024 · Immunological Reviews
New era of cancer immunology driven by big data
Chunhong Zheng, Zemin Zhang · 2023 · Medical Review
Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer
Yalong Qi, Hewei Ge, Xiaoying Sun, Yuhan Wei, Jingtong Zhai, Haili Qian, Hongnan Mo, Fei Ma · 2025 · Journal of Autoimmunity
CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancers
Xiao‐Liang Jie, Jia-Cong Wei, Di Wang, Xiang-Wei Zhang, MingYue Lv, Yong-Fang Lin, Yadi Tan, Zheng Wang, Aikede Alifu, Lei Ji et al. · 2025 · Cancer Letters
Integrated Analysis of Ferroptosis- and Cellular Senescence-Related Biomarkers in Atherosclerosis Based on Machine Learning and Single-Cell Sequencing Data
xiang qi, Shan Cao, Jian Chen, xiaolei yin · 2025 · Journal of Inflammation Research
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer
Seung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, Minwoo Jeon, Ho Cheol Jang, Eui-Soon Kim, Se Hyun Kim, Kyung-Hun Lee, Seock‐Ah Im, Min Hwan Kim et al. · 2025 · Clinical Cancer Research
Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling
Dianqi Cai, Chao Zhu, Haoxuan Huang, Yuchen Cao, Gengxi Cai, Zijun Chen, Junjie Feng, Weiqi Zhang, Wenjun Mao, Jianguo Lai · 2025 · Research
Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial
Qin Tan, Yifei Li, Caixia Liu, Jing Xu, Jinlian Tong, Jiangyong Yu, Yingying Huang, Xueqing Hu, Sen Qin, Fei Xiao et al. · 2025 · Signal Transduction and Targeted Therapy
Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis
Cong Dong, Bingtai Lu, Changhao Zhong, Changxing Ou, Xiaojing Yang, Lingwei Wang, Xiaoyu Zuo, Lingna Xue, Chenyang Lu, Shang Wang et al. · 2026 · Nature Communications
PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells
Keling Huang, Xiaoxue Li, Wenhua Liang, Shuyao Wu, Youqiong Ye, Yan Lu, JunKe Zheng, Weifang Wang, Qifan Zheng, Guo Fu et al. · 2026 · Science Immunology
Evaluating deconvolution methods using real bulk RNA-expression data for robust prognostic insights across cancer types
Minghan Li, Yuqing Su, Yizhou Tang, Yuehfan Lee, Weidong Tian · 2026 · Genome biology
Decoding tumor immune microenvironment heterogeneity by single-cell and spatial multi-omics: From immunotherapy resistance to translational biomarkers
Tingting Shi, Yanan Guo, Xiaoting Tang, Zhenmin Liu, Qian Guo, Taiyong Fang, Shengshan Xu, Zehao Zhuang · 2026 · Neoplasia
KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1
Bin Xiao, Qin Xiang, Zihua Deng, Daxiang Chen, Shunhong Wu, Yanxia Zhang, Yaru Liang, Wei Shi, Guoqing Luo, Linhai Li · 2023 · Carcinogenesis
Effect of AGEs-RAGE system on the efficacy of PD-1 inhibitors in the treatment of driver-gene mutation negative advanced non-squamous non-small cell lung cancer
Xiangying Li, Guan Wang, Xiuye Sun, Yue Feng, Lei Wang, Gangyuan Sun, Hong Qiao · 2023 · Cellular and Molecular Biology
One-carbon metabolism is distinct metabolic signature for proliferative intermediate exhausted T cells of ICB-resistant cancer patients
Ye-Chan Park, Yeseong Hwang, Jae Woong Jeong, Chae Min Lee, Minki Kim, Sugyeong Jo, Seyeon Joo, Nahee Hwang, Sungsoon Fang · 2025 · Cell Death Discovery
The Dynamically Evolving Cell States and Ecosystem from Benign Nevi to Melanoma
Xin Li, Xiyuan Zhang, Shuang Zhao, Shiyao Pei, Jie Sun, Liang Dong, Xu Pan, Wenhua Wang, Hao Liu, Yaoxuan Huang et al. · 2025 · Clinical Cancer Research
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes
Avia D. Wilkerson, Ivan Jurić, Salendra Singh, Patricia A. Rayman, Paul G. Pavicic, Jennifer Powers, Prerana Bangalore Parthasarathy, Zahraa Al‐Hilli, Jennifer S. Ko, Timothy An-thy Chan et al. · 2025 · Communications Medicine
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase et al. · 2022 · Advances in clinical chemistry
scGEM: Unveiling the Nested Tree-Structured Gene Co-Expressing Modules in Single Cell Transcriptome Data
Han Zhang, Xinghua Lu, Binfeng Lu, Lujia Chen · 2023 · Cancers
Deciphering pathological behavior of pediatric medullary thyroid cancer from single-cell perspective
Deqian Chen, E Yihui Zhou, Huifen Chen, Yong Zhan, Chunjing Ye, Yi Li, Shu-yang Dai, Junfeng Wang, Lian Chen, Kuiran Dong et al. · 2023 · PeerJ
The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer
Ziqi Zhao, Xinyu Ma, Zhengang Cai · 2024 · PeerJ
Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease
Minyue Qian, Jia Zhong, Zhongteng Lu, Wenyuan Zhang, Mengcao Weng, Kai Zhang, Yue Jin · 2024 · International Journal of Medical Sciences
Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma
Xia Li, Zhao Zhao, Yanmei Cheng, Jiaqin Yan, Fang Ren, Yanyan Jia, Juanhua Li, Binhui Wang, Junqi Liu, Chenyin Wang et al. · 2025 · Cancer Cell International
Synergistic Induction of Immunogenic Cell Death by Biomineralized Manganese and Bisphosphonates Enhances Anti-PD-L1 Therapy in Triple-Negative Breast Cancer
Xiuli Zhang, Nan Liu, Mingjing Wei, Chuanlai Yang, Yanhua Lin, Yarong Zeng, Yufang Li, Lizhi Zhou, Tingting Li, Qingbing Zheng et al. · 2025 · International Journal of Nanomedicine
Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
Xia Li, Yanmei Cheng, Mei Ji, Junqi Liu, Zhao Zhao, Qitai Zhao · 2025 · Cancer Immunology Immunotherapy
Heterogeneity of immune infiltration and immunotherapy in colorectal cancer
Yichen Li, Jun X. Hu, Min Zhi · 2023 · Gastroenterology report
Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast Cancer
Shalini Bahl, Jason S. Carroll, Mathieu Lupien · 2022 · Cold Spring Harbor Perspectives in Medicine
Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, Angela Orcurto, Julien Dagher, Noémie Fahr, Fabrizio Benedetti, Isaac Crespo, Stefan Zimmermann, Rafael Durán et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Lactate Blocks Tertiary Lymphoid Structure Formation by Inhibiting B Cell Chemotaxis
Victoire Boulat, Elena Alberts, Paul C. Driscoll, Miu Shing Hung, Ana Cunha, Jelmar Quist, Fangfang Liu, Carin Andrea Brundin, Ananya Bhalla, Lidia Avalle et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Immature monocytic cells within tumors differentiate into immunosuppressive cells in resistant tumors to immunotherapy
Sapir Levin, Madeleine Benguigui, Bar Manobla, Chen Buxbaum, Ziv Raviv, Keren Yizhak, Yuval Shaked · 2025 · iScience
Identification and Characterization of Cytokine Genes in Breast Cancer for Predicting Clinical Outcomes
Zhifen Han, Yi Yuan, Min Hu, Jinxiang Wang, Bing Gao, Xiaoxi Sha · 2025 · Mediators of Inflammation
Stress‐Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast Cancer
Zhibo Shao, Xuliren Wang, Han Jian Zhu, Ling Yao, Q Zhang, Zihan Zhai, Xinyi Lv, Xinyuan Xia, Yi Zhang, Xinya Lu et al. · 2026 · Advanced Science
Comprehensive tumour‐immune profiling reveals TREM2 + tumour‐associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma
Zhuokai Wu, C. Cheng, Z Li, Minyi Ren, Hongxi Cao, Weijie Huang, Jun Wang, Lixian Wu, Tingyi Lee, Sien Zhang et al. · 2026 · Clinical and Translational Medicine
Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review
Sung Ae Koh · 2026 · Journal of Yeungnam Medical Science
Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer
Yaoyi Dai, Xiaoxi Pan, Shuai Guo, Shuangxi Ji, Shaolong Cao, Matthew D. Montierth, Yujie Jiang, Jeffrey T. Chang, Leming Shi, Shabnam Shalapour et al. · 2026 · Cell Reports Medicine
Single-cell and spatial profiling reveal cDC2A-CXCL13+CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus
Run-Dong Jiang, Rachael Bogle, Xian-Ying Xing, J. Kirma, Jennifer Fox, Paul W. Harms, Do Tran, A. Billi, J. Kahlenberg, R. Modlin et al. · 2026 · Nature Communications
The cellular actors of the tumor microenvironment: a single-cell atlas perspective on specialized subtypes, coordinated networks, and immunotherapy
Linnan Zhu, Nan Jiang, Zemin Zhang · 2026 · Immunity & Inflammation
Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer
Rong Tang, Liquan Jin, Chen Chen, Yingna Liao, Dingru Li, Yaqi Li, Yueyue Chen, Yunhe Liu, Qiong Du, Zeyin Rong et al. · 2026 · Cancer Cell
scRNA+TCR+BCR-seq revealed the proportions and gene expression patterns of dual receptor T and B lymphocytes in NPC and NLH
Yuanning Yao, Hengyu Wang, Yuanyuan Xu, Li Zhang, Renping Liu · 2024 · Biochemical and Biophysical Research Communications
ReCIDE: robust estimation of cell type proportions by integrating single-reference-based deconvolutions
Minghan Li, Yuqing Su, Yanbo Gao, Weidong Tian · 2024 · Briefings in Bioinformatics
Research progress and prospect of tumor nanovaccine combination therapy strategy
Yanyan Yin, Jun Guo, Shuo Zhang, Meng Xu, Yun Zhi Fu, Mengyi Zhang, Zhiyuan Ma, Jiajia Ji, Siyuan Wu, Jinjie Zhang et al. · 2024 · Chinese Chemical Letters
An activin receptor-like kinase 1–governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases
Mehrnaz Safaee Talkhoncheh, Jonas Sjölund, Paulina Bolívar, Ewa Kurzejamska, Eugenia Cordero, Teia Vallès Pagès, Sara Larsson, Sophie Lehn, Gustav Frimannsson, Viktor Ingesson et al. · 2025 · Journal of Clinical Investigation
Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, Qian Liu, Henry Rodriguez, Hu Zhou · 2025 · Biophysics Reports